Skip to main content
Premium Trial:

Request an Annual Quote

Gyros Pockets $6M More for Series B Round

NEW YORK, April 11 - Swedish mass-spec company Gyros today said it has closed an additional $6 million in its second private-equity round of financing, bringing to $36 million the total second-round booty.

 

Gyros recently unveiled its Gyrolab MALDI SP1 and Gyrolab Workstation, both of which will be shown off at a number of meetings in the US and Europe in the coming months.

 

In January, Gyros said it and ACE BioSciences plan to test its new technique for miniaturizing and automating sample preparation for protein identification.

 

The Gyros system is designed to automate sample prep for MALDI mass spectrometry and boost sensitivity in protein identification. It is a new application of the company's core platform, by which laboratory processes are miniaturized and embedded into CDs for parallel preparation and processing.

 

Gyros, based in Uppsala, was spun off from Amersham Pharmacia Biotech in 2000.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.